Dr Eroglu on Addressing Unmet Needs in Mutant Melanoma
Zeynep Eroglu, MD, discusses a phase 1/2 trial that evaluated ceritinib alone and in combination with trametinib in patients with mutant melanoma.
Source: onclive.com
Zeynep Eroglu News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Zeynep Eroglu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Zeynep Eroglu Today - Breaking & Trending Today
Dr Eroglu on Ceritinib With or Without Trametinib in Pretreated Advanced Melanoma
Zeynep Eroglu, MD, discusses the efficacy and safety of ceritinib as monotherapy and in combination with trametinib in pretreated advanced melanoma.
Source: onclive.com
Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma
Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.
Source: onclive.com
Dr Eroglu on the Safety Profile of Ceritinib Plus Trametinib in Advanced Melanoma
Zeynep Eroglu, MD, discusses the safety profile of ceritinib plus trametinib in pretreated metastatic melanoma.
Source: onclive.com
Dr Eroglu on Future Steps for Assessing Ceritinib Plus Trametinib in Metastatic Melanoma
Zeynep Eroglu, MD, discusses future steps for assessing ceritinib in combination with trametinib in patients with metastatic melanoma.
Source: onclive.com